Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Aurora-A promotes lenvatinib resistance experimentally through hsa-circ-0058046/miR-424-5p/FGFR1 axis in hepatocellular carcinoma

Mubalake Abudoureyimu, Ni Sun, Weiwei Chen [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2024-12-13

Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer

Sonam Kumari, Shilpa Thakur, Stephanie Cardenas [...]

VideoEndocrinology™

Retricted access

Research article

First published 2022-02

Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer

Bruna C. Bertol, Elise S. Bales, Jacob D. Calhoun [...]

Thyroid®

Retricted access

Research article

First published 2015-04

Lenvatinib Increases Progression-free Survival in Patients with Metastatic Radioiodine-Resistant Differentiated Thyroid Cancer

Jerome M. Hershman

Clinical Thyroidology®

Retricted access

Research article

First published 2023-07

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

Asumi Iesato, Stephanie Li, Peter M. Sadow [...]

Thyroid®

Retricted access

Research article

First published 2024-03

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Jaume Capdevila, Jolanta Krajewska, Jorge Hernando [...]

Thyroid®

Retricted access

Research article

First published 2020-02

Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences

Chie Masaki, Kiminori Sugino, Naoko Saito [...]

Thyroid®

Retricted access

Research article

First published 2018-01

Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma

Priyanka C. Iyer, Ramona Dadu, Renata Ferrarotto [...]

Thyroid®

Open access

Article commentary

First published 2025-7

Role of immune check point inhibitor rechallenge in metastatic renal cell carcinoma

Hatice Bölek, Satı Coşkun Yazgan, Yüksel Ürün [...]

Kidney Cancer

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

Search results